Risk factors for recurrence of vulvar intraepithelial neoplasia III (VIN III);Risikofaktoren der rezidivhäufigkeit von vulvären intraepithelialen neoplasien grad III (VIN III)

Zentralblatt fur Gynakologie

Volumn 128, Issue 6, 2006, Pages 347-351

  Ahr, André ^a   Rody, A ^b   Kissler, S ^b   Kaufmann, M ^b   Gatje R ^b  

^a Gynäkologische Praxis am Ziegelturm ^*  (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

HIV; HPV; Recurrence; Resection margin; VIN

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS; VULVA TUMOR; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; ANALYSIS OF VARIANCE; CARCINOMA IN SITU; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; REOPERATION; RISK FACTORS; VULVAR NEOPLASMS;

EID: 33846222262     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-942280     Document Type: Article

References (20)

1. Ahr A, Scharl A, Lutke K, Staszewski S, Kacer PZ, Kaufmann M. Cervical intraepithelial neoplasia in human immunodeficiency virus-positive patients. Cancer Detect Prev 2000; 24: 179-185
2. Ahr A. Vulva-Sprechstunde - aktuelle Aspekte der Diagnostik und Therapie von Lichen sclerosus, VIN und Condylomata acuminata. Gyn 2002; 7: 322-327
3. Ahr A, Cimpoiasu C, Faul-Burbes C, Kissler S, Kaufmann M, Gätje R. Zervixkarzinom-Früherkennung bei HIV-positiven Frauen - Ist eine Verlängerung des Screeningintervalls sinnvoll? Zentralbl Gynakol; in Druck
4. Ait Menguellet S, Collinet P, Debarge VH, Nayama M, Vinatie D, Leroy JL. Management of multicentric lesions of the lower genital tract. Eur J Obstet Gynecol Reprod Biol 2006; [Epub ahead of print]
5. Almeida G, Do Val I, Gondim C, Lima R, Takiya C, Carvalho G. Human papillomavirus, Epstein-Barr virus and p53 mutation in vulvar intraepithelial neoplasia. J Reprod Med 2004; 49: 796-799
6. Anderson MC, Jordan JA, Morse AR, Scharp F, Stafl A. Vulval disease and vulval intraepithelial neoplasia. In: Anderson MC, Jordan JA, Morse AF, Sharp F. Integrated Colposcopy. Chapman & Hall 1996
7. AWMF-online. Empfehlungen zur Diagnostik und Therapie von HPV-INfektionen des weiblichen Genitale. http://www.uni-duesseldorf.de/ WWW/AWMF/11/015-027.htm
8. AWMF-online. Vulvakarzinom. http://leitlinien.net/
9. Edwards L, Tortolero-Luna G, Lineares AC, Mailpica A, Baker W, Cook E, Johnson E, Follen Mitchell M. Vulvar intraepithelial neoplasia and vulvar cancer. Obstet Gynecol Clin North Am 1996; 23: 295-324
10. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997; 90: 748-754
11. Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol 2006; 100: 271-275
12. Hillemanns P, Wang X. Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Gynecol Oncol 2006; 100: 276-282
13. Jamieson DJ, Paramsthy P, Cu-Uvin S, Duerr A. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 2006; 107: 1023-1028
14. Jones RW, Rowan DM, Stewart RW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol 2005; 106: 1319-1326
15. Korn AP, Abercombie PD, Foster A. Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1. Gynecol Oncol 1996; 61: 384-386
16. Küppers V, Stiller M, Somville T, Bender HG. Risk factors for recurrent VIN. Role of multifocality and grade of disease. J Reprod Med 1997; 42: 140-144
17. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, Kurman RJ, Beckmann AM, Hegensee ME, Galloway DA. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89: 1516-1523
18. McNally OM, Mulvany NJ, Palgano R, Quinn MA, Rome RM. VIN 3: a clinicopathologic review. Int J Gynecol Cancer 2002; 12: 490-495
19. Modesitt SC, Waters AB, Walton L, Fowler JrEC, Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol 1998; 92: 962-966
20. Van Seters M, Van Beurden M, De Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 645-651